CompletedNCT01518309
Safety study of pimavanserin in Schizophrenia
This study is completed in the United States. It is testing pimavanserin for Schizophrenia.
In United StatesSchizophreniaDrugA study involving a medication or substance.
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02320032
An Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
This study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
Enrolling By InvitationNCT07217860
An Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
This study is enrolling by invitation in the United States. It is testing azetukalner for depression.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 75 Years
Enrolling By InvitationNCT06922110
An Study of Azetukalner in Major Depressive Disorder
This study is enrolling by invitation in the United States. It is testing azetukalner for depression.
In United StatesDepressionDrugOver 18 Years
CompletedNCT00269594
An Study Of Lamictal In Neurotic Excoriation
This study is completed in the United States. It is testing lamictal for OCD.
In United StatesOCDDrugFrom 18 Years to 65 Years
CompletedNCT05061719
Lumateperone for depression
This study is completed in the United States, in Bulgaria, in Czechia, .... It is testing lumateperone for depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
CompletedNCT01873729
An Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
This study is completed in the United States. It is testing naltrexone for ADHD.
In United StatesADHDDrugFrom 18 Years to 55 Years
CompletedNCT00337285
An Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study is completed in the United States. It is testing NRP104 for ADHD.
In United StatesADHDDrugFrom 18 Years to 55 Years
CompletedNCT04820309
Safety study of Long-term Safety, Tolerability, and Efficacy of KarXT in schizophrenia
This study is completed in the United States. It is testing Long-term Safety, Tolerability, and Efficacy of KarXT for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
TerminatedNCT05643170
Effectiveness of Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in schizophrenia
This study was terminated in the United States. It is testing Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT01850355
An study of Buspirone for Anxiety in Youth With Autism Spectrum Disorders
This study is completed in the United States. It focuses on anxiety.
In United StatesAnxietyDrugFrom 6 Years to 17 Years
CompletedNCT02258828
An study of Memantine for Cognitive Impairment in people with PTSD
This study is completed in the United States. It focuses on PTSD.
In United StatesPTSDDrugFrom 19 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.